source Post navigation Expert Consensus on Dipeptidyl Peptidase-4 Inhibitor-Based Therapies in the Modern Era of Type 2 Diabetes Mellitus … – Cureus U.S. FDA places clinical hold on Biomea's diabetes trials – ETHealthWorld